Urinary Obstruction
9
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
83.3%
-3.3% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (9)
NXT Post-Market Clinical Follow-up
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS
Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial
Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction
The Importance of Non-invasive Methods in the Diagnosis of Lower Urinary System Symptoms.
BE Technologies Mobile Uroflowmetry Validation Study